[1]
Kaveh, S., Ebrahimi, P., Rezapour, A., Mozafari, M. and Sayehmiri, K. 2018. Health technology assessment of Bevacizumab compare with combination of Bevacizumab with Erlotinib for treatment of patients with metastatic colorectal cancer. International Pharmacy Acta. 1, 1 (Mar. 2018), 19–20. DOI:https://doi.org/10.22037/ipa.v1i1.20015.